Senior insider sale
Y-MABS THERAPEUTICS, INC. — senior position signals high conviction
$8.7K
722.00 shares
What this filing means
BER GERARD plans to sell 722.00 shares of Y-MABS THERAPEUTICS, INC. valued at approximately $8.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/10/2024ACC: 0001964306-24-000248
722.00
Shares to sell
$8.7K
Approx. market value
722.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
6/8/2024
722.00Total acquired722.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/8/2024 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 722.00 | — |
| Total | 722.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
722.00
Market value
$8.7K
6/10/2024
Total
Units
722.00
Value
$8.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/10/2024 | 722.00 | $8.7K | NASDAQ | Planned |
| Total | 722.00 | $8.7K | ||